NUTRA PHARMA CORP. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NUTRA PHARMA CORP. stock issued during period, value, other for the quarter ending 2022-12-31 was $0.00.
- NUTRA PHARMA CORP. stock issued during period, value, other for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. stock issued during period, value, other for the quarter ending 2022-06-30 was $222.50K, a 1363.91% increase year-over-year.
- NUTRA PHARMA CORP. stock issued during period, value, other for the quarter ending 2022-03-31 was $54.25K, a 87.88% decline year-over-year.
- NUTRA PHARMA CORP. stock issued during period, value, other for fiscal 2022 was $276.75K, a 48.35% decline from fiscal 2021.
- NUTRA PHARMA CORP. stock issued during period, value, other for fiscal 2021 was $535.79K, a 512.33% increase from fiscal 2020.
- NUTRA PHARMA CORP. stock issued during period, value, other for fiscal 2020 was $87.50K, a 82.01% decline from fiscal 2019.
- NUTRA PHARMA CORP. stock issued during period, value, other for fiscal 2019 was $486.40K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2025-12-31 | $10.00K 10-Q · filed 2026-03-25 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-24 | $276.75K 10-K · filed 2025-11-24 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $276.75K derived: sum of 4 quarters · filed 2025-10-28 |
| 2022-06-30 | $222.50K 10-Q · filed 2025-10-23 | $349.78K derived: sum of 4 quarters · filed 2025-10-23 |
| 2022-03-31 | $54.25K 10-Q · filed 2025-10-16 | $142.48K derived: sum of 4 quarters · filed 2025-10-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-03 | $535.79K 10-K · filed 2025-09-03 |
| 2021-09-30 | $73.03K 10-Q · filed 2022-11-21 | $535.79K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $15.20K 10-Q · filed 2022-08-22 | $462.75K derived: sum of 4 quarters · filed 2022-08-22 |
| 2021-03-31 | $447.56K 10-Q · filed 2022-05-20 | $447.56K derived: sum of 4 quarters · filed 2022-05-20 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $87.50K 10-K · filed 2022-04-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $541.50K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | $541.50K derived: sum of 4 quarters · filed 2021-09-24 |
| 2020-03-31 | $87.50K 10-Q · filed 2021-09-17 | $541.50K derived: sum of 4 quarters · filed 2021-09-17 |
| 2019-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-08 | $486.40K 10-K · filed 2021-09-08 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $42.18K derived: sum of 4 quarters · filed 2021-08-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | |
| 2019-03-31 | $32.40K 10-Q · filed 2021-07-23 | |
| 2018-12-31 | $9.78K 10-K · filed 2021-02-05 | |
| 2015-12-31 | $23.44K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $33.44K 10-K · filed 2017-04-17 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | $10.00K derived: sum of 4 quarters · filed 2016-06-21 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | $10.00K derived: sum of 4 quarters · filed 2016-06-21 |
| 2015-03-31 | $10.00K 10-Q · filed 2016-06-21 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-13 | $100.00K 10-K · filed 2015-04-13 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-13 | $162.50K 10-K · filed 2015-04-13 |
| 2013-09-30 | $62.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 |